Nuevolution AB

Figuring out how to get a foot in the door with potential big pharma partners is a daunting task for academic researchers and small biotechnology companies. The organizers of the inaugural American As

R&D leaders from Amgen, Inc. , Johnson & Johnson and Takeda Pharmaceutical Co. Ltd. deliberated, at a recent summit, the potential of big data to uncover biological insights and complex issues ar

Amgen, Inc. acknowledged during its business review on 8 February that drug pricing and competitive pressures are growing hurdles for the biopharmaceutical industry through the end of this decade. As

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Lilly Pays $47.5m Up Front F